Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1)

Protocol
12-241
Full Title
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer(COG-ALTE07C1)
Disease Status
Newly Diagnosed
Purpose

Pediatric cancer and its treatment may cause problems with learning, thinking, and behavior (“neuropsychological problems”). Children may have difficulty remembering things, paying attention, planning ahead, and keeping up with their classmates at school.

The purpose of this Children’s Oncology Group study is to assess the neuropsychological, social, emotional, and behavioral functioning of children being treated for cancer. Participants will undergo neuropsychological evaluation at three points during and after cancer treatment: 9 months, 2.5 years, and 5 years after being diagnosed with cancer.

Eligibility

This study is open to English-speaking children (ages 3-21) with cancer who are participating in a Children’s Oncology Group therapeutic study.

For more information about this study, please contact Dr. Ira Dunkel at 212-639-2153.

Disease(s)
Survivorship
Locations

Cancer Clinical Trials: Personalizing for Each Patient

Join our experts for a discussion of clinical trials on November 18. Clinical trials can give patients access to new drugs and other treatments before they are widely available, but how do you know if a trial is right for you?

Learn more »